UCL 1684

Term ID

CHEBI:35040

Synonyms

1(1)lambda(5),5(1)lambda(5)-6,10-diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)-diquinolinacyclodecaphane-1(1),5(1)-bis(ylium)
17,24-diaza-1,9-diazoniaheptacyclo[23.6.2.2(9,16).2(19,22).1(3,7).0(10,15).0(26,31)]octatriaconta-1(32),3(38),4,6,9(37),10(15),11,13,16(36),19,21,25(33),26(31),27,29,34-hexadecaene
1lambda(5),9lambda(5),17,24-tetraazaheptacyclo[23.6.2.2(9,16).2(19,22).1(3,7).0(10,15).0(26,31)]octatriaconta-1(32),3(38),4,6,9(37),10(15),11,13,16(36),19,21,25(33),26(31),27,29,34-hexadecaene-1,9-bis(ylium)
6,10-diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)-diquinolinacyclodecaphane
UCL-1684
UCL1684

Definition

A quinolinium ion that is the dication which results from the joining of two molecules of 4-aminoquinolinium via a 1,3-dimethylbenzene linker at positions 1 and 4, thus forming a cyclic structure. It is a potent blocker of Ca²⁺-activated K⁺ channels in rats.

References

chemspider:571070
kegg.compound:C13783
pubmed:10096777
pubmed:10669569
pubmed:10696100
pubmed:10742299
pubmed:10742306
pubmed:12678783
pubmed:15180477
pubmed:15655533
pubmed:16186562
pubmed:17209000
pubmed:18574459
pubmed:18783364
pubmed:19645713
pubmed:19766962
pubmed:19820882
pubmed:20040579
pubmed:21297022
pubmed:21394037
pubmed:21502564
pubmed:21665944
pubmed:22242975
pubmed:22331352
pubmed:23086994
pubmed:23376397
pubmed:23488619
pubmed:23685886
pubmed:24390175
pubmed:24703998
pubmed:25344384
pubmed:25421636
pubmed:25652142
pubmed:26825543
pubmed:28981145
pubmed:29330041
pubmed:29631373
pubmed:30694690
pubmed:32453071
pubmed:33041794
pubmed:9438015

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from UCL 1684

Phenotype where environments contain UCL 1684

Phenotype modified by environments containing UCL 1684

Phenotype affecting UCL 1684

Human Disease Model